• About Us
  • Board of Advisors
  • Contact

MALARIA.com

A Malaria Information and Community Portal

  • Home
  • Malaria Overview
  • Malaria Research
  • News
  • Videos
  • Blogs
  • Malaria Q&A
  • Events
  • Jobs
Home / Malaria News / Exchange Transfusion for Treatment of Severe Malaria No Longer Recommended

Exchange Transfusion for Treatment of Severe Malaria No Longer Recommended

July 15, 2013 By Malaria.com Leave a Comment

The Centers for Disease Control (CDC) no longer recommends the use of exchange transfusion (ET) as an adjunct to antimalarial drugs for the treatment of severe malaria.

ET is a procedure in which a portion of blood from the infected patient is removed and replaced with uninfected blood. Previously, the rationale for the use of ET in severe malaria was that ET removed infected cells and toxic byproducts. ET has been used in countries like the United States to complement antimalarials when treating severe malaria. In fact, CDC used to recommend that ET could be considered as an adjunct to intravenous quinidine in patients with very high parasite loads (>10%), or if complications such as cerebral malaria, acute respiratory distress syndrome, or renal compromise occur. However, the use of ET has been based on limited evidence.

CDC examined the efficacy of ET as an adjunct treatment for severe malaria by analyzing data from the US National Malaria Surveillance System and reviewed the entirety of the published literature to update recommendations. Patients with severe malaria who were treated with ET were compared to those not treated with ET, and there was no significant association between ET and survival outcome. A review of the literature found that the evidence available was limited but overall showed no differences in outcome when ET was used. Adverse events due to ET were rarely reported but included acute respiratory distress syndrome, ventricular fibrillation, and hypotension. To date, this is the largest and most comprehensive study of exchange transfusion for treatment of severe malaria. Based on this evidence, adjunct ET cannot be recommended for the treatment of severe malaria.

Source: CDC

Filed Under: Malaria News Tagged With: CDC, Exchange Transfusion

Leave a Reply Cancel reply

You must be logged in to post a comment.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Stay Informed

WWARN Corner

About WWARN

The WorldWide Antimalarial Resistance Network (WWARN) generates innovative resources and reliable evidence to inform the malaria community on the factors affecting the efficacy of antimalarial medicines. Learn more…

  • Fighting Malaria Requires Protecting the Effectiveness of Antimalarial Medicines
  • Data Sharing at IDDO
  • Evidence to inform equitable dosing in very young and malnourished children

More WWARN Stories...

  • Home
  • Malaria Overview
  • Malaria Research
  • News
  • Videos
  • Blogs
  • Malaria Q&A
  • Events
  • Jobs
  • About Us
  • Board of Advisors
  • Contact

Copyright © 2025 Malaria.com ยท Log in